The Astronaut Who Could Rewrite Space Medicine

John McFall may become the first person with a physical disability to live in orbit. What his mission to Haven-1 means for the future of human spaceflight.

By The space-quantum Desk

John McFall is a surgeon and a European Space Agency reserve astronaut who lost his right leg in a motorcycle accident. In 2022, ESA selected him under the Fly! Project, a program designed to pioneer the inclusion of astronauts with physical disabilities in space. [1] Now the U.K. government is working to send him somewhere no person with a physical disability has ever been: a full-duration stay in low Earth orbit.

On June 2, the UK Space Agency announced an agreement with Vast, a U.S.-based commercial station developer, to support the company in securing sponsorships for a 14-day mission aboard Haven-1. [1] The goal, according to the agency, is for sponsorship to cover the mission's full cost. If it launches and McFall boards, he would become the first person with a physical disability to live in orbit.

Haven-1 is a single-module station scheduled to launch on a Falcon 9 rocket, with the station designed to start accommodating four crew members between a few weeks and a few months after launch, using SpaceX's Crew Dragon spacecraft. [1] It is currently planned to stay in low Earth orbit for three years, after which Vast intends it to serve as a stepping stone to Haven-2, a continuously crewed, multi-module successor.

Commercial space is moving fast, and the passenger manifest is slowly changing shape. The question is no longer simply who can afford a seat, but who the industry has decided belongs in one.

McFall's prospective research agenda aboard Haven-1 is not ceremonial. He would conduct work into human physiology, musculoskeletal adaptation, prosthetic performance in microgravity, and how people move in orbit. [1] That last item is deceptively complex: the biomechanics of a limb-different body in a weightless environment are essentially unstudied at the long-duration scale, and the data McFall could generate would open lines of inquiry with direct applications back on Earth.

Last year, McFall became the first person with a physical disability to be medically cleared for a long-duration mission. [1] The clearance itself was a research project — ESA had to develop new evaluation frameworks to assess how a body like McFall's would respond to the stresses of spaceflight. The clinical and regulatory work that produced that certification is, in some ways, as significant as any single mission.

Milestones in human spaceflight tend to arrive in two flavors: the ones that extend where humans can go, and the ones that expand who counts as a human capable of going there. The second kind are rarer, harder, and more durable.

The comparison point the U.K. government is using is Tim Peake's 2015 mission to the International Space Station. [1] A spot on Haven-1 would make McFall the first British person to reach orbit in more than a decade — a fact that carries its own political weight inside a government that has been eager to cement the country's identity as a serious player in commercial spaceflight.

British Space Minister Liz Lloyd stated: "This agreement with Vast brings us one step closer to making history, and to showing the world that space is for everyone." [1] That framing — space for everyone — has become a standard line in the commercial era, but it carries different stakes when attached to a specific person, a specific disability, and a specific set of unanswered physiological questions.

Vast declined to specify how much sponsorship it requires to fund the mission. [1] The agency agreement obligates UKSA to support meetings with potential sponsors and to assist with legal and regulatory requirements, but the financial architecture remains open. That structure places the mission in a holding pattern familiar to anyone who has watched the commercial human spaceflight sector: announced, credible in principle, and dependent on private capital that has not yet materialized.

The precedent here is not reassuring. In 2023, the UK Space Agency announced a similar agreement with Axiom Space — also Houston-based, also developing its own station — to pursue a fully commercially sponsored U.K. astronaut mission to the ISS. [1] That agreement set out plans for the two organizations to work together to pursue a commercially sponsored UK astronaut mission, with UK astronauts spending up to two weeks on orbit to carry out scientific research, demonstrate new technologies, and participate in education and outreach activities. [2] That effort has made little public progress since.

[2] The choreography was explicit: space missions as financial signals, not just scientific ones. The Vast agreement follows a similar pattern, announced the day after Vast unveiled plans for a Paris headquarters and lined up two French astronauts for its missions, including one designated for the first flight to Haven-1. [1]

There is a tension at the center of all of this that the press releases do not resolve. Inclusion and commerce are not natural allies. One operates on the logic of equity; the other on the logic of return. When the funding model for a historic mission depends entirely on sponsorship, the mission exists only if it is marketable enough.

In December, Michaela Benthaus, a German engineer at ESA, became the first wheelchair user to reach space on a Blue Origin suborbital flight that lasted about 10 minutes. [1] That flight and McFall's prospective mission are separated by duration, orbital altitude, and scientific depth — but they share a category. Each represents the industry testing what the body of inclusion policy it has accumulated actually means in practice.

The agreement between UKSA and Vast also establishes a broader framework covering scientific research, technology development in low Earth orbit, education, and public engagement. [1] Daniel Neuenschwander, ESA's Director of Human and Robotic Exploration, noted in the context of the earlier Axiom agreement: "This unique flight will allow ESA to enhance its actions with new partnership schemes and implement together with the United Kingdom a series of research experiments, which will further deepen the knowledge on exploration in and for Europe." [2] Haven-1, if it flies on schedule and McFall is aboard, would represent the most tangible expression of that agenda yet.

Haven-1 is slated to launch on a Falcon 9 next year, and McFall's mission is planned for some time after that. [1] The schedule is tight. The funding is unconfirmed. The research questions are real and the regulatory precedent is already set. What remains is the harder work: finding the money, closing the contracts, and actually getting a surgeon with one leg onto a spacecraft heading to orbit.

Space has always been a place where the definition of who qualifies keeps expanding — slowly, unevenly, and usually only after someone does the unglamorous work of proving it is possible. McFall did that work on the ground. The next question is whether the commercial infrastructure around him can do its part. [1]